{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T18:18:25Z","timestamp":1792606705473,"version":"4.5.0"},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1093\/jnci\/djn378","type":"journal-article","created":{"date-parts":[[2008,11,12]],"date-time":"2008-11-12T02:09:10Z","timestamp":1226455750000},"page":"1630-1642","source":"Crossref","is-referenced-by-count":181,"title":["Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer Cells"],"prefix":"10.1093","volume":"100","author":[{"given":"Shuangxing","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mandi M.","family":"Murph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan S.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianjun","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon B.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,11,19]]},"reference":[{"issue":"8","key":"key\n\t\t\t\t20170715051736_bib1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc1143","article-title":"The emerging role of lysophosphatidic acid in cancer","volume":"3","author":"Mills","year":"2003","journal-title":"Nat Rev."},{"issue":"8","key":"key\n\t\t\t\t20170715051736_bib2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/bies.20081","article-title":"The ins and outs of lysophosphatidic acid signaling","volume":"26","author":"Moolenaar","year":"2004","journal-title":"Bioessays"},{"issue":"4","key":"key\n\t\t\t\t20170715051736_bib3","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","article-title":"Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex","volume":"135","author":"Hecht","year":"1996","journal-title":"J Cell Biol."},{"issue":"14","key":"key\n\t\t\t\t20170715051736_bib4","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1074\/jbc.273.14.7906","article-title":"Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid","volume":"273","author":"An","year":"1998","journal-title":"J Biol Chem."},{"issue":"39","key":"key\n\t\t\t\t20170715051736_bib5","doi-asserted-by":"crossref","first-page":"27776","DOI":"10.1074\/jbc.274.39.27776","article-title":"Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid","volume":"274","author":"Bandoh","year":"1999","journal-title":"J Biol Chem."},{"key":"key\n\t\t\t\t20170715051736_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-1-4615-4793-8_38","article-title":"A subfamily of G protein-coupled cellular receptors for lysophospholipids and lysosphingolipids","volume":"469","author":"Goetzl","year":"2001","journal-title":"Adv Exp Med Biol."},{"issue":"1\u20134","key":"key\n\t\t\t\t20170715051736_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0090-6980(01)00109-5","article-title":"Sphingosine 1-phosphate receptors","volume":"64","author":"Hla","year":"2001","journal-title":"Prostaglandins"},{"issue":"10","key":"key\n\t\t\t\t20170715051736_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.bbalip.2006.08.011","article-title":"Homo- and hetero-dimerization of LPA\/S1P receptors, OGR1 and GPR4","volume":"1761","author":"Zaslavsky","year":"2006","journal-title":"Biochim Biophys Acta"},{"issue":"28","key":"key\n\t\t\t\t20170715051736_bib9","doi-asserted-by":"crossref","first-page":"25600","DOI":"10.1074\/jbc.M302648200","article-title":"Identification of p2y9\/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family","volume":"278","author":"Noguchi","year":"2003","journal-title":"J Biol Chem."},{"issue":"2","key":"key\n\t\t\t\t20170715051736_bib10","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/jpet.105.098848","article-title":"Lysophosphatidic acid binds to and activates GPR92, a G protein-coupled receptor highly expressed in gastrointestinal lymphocytes","volume":"318","author":"Kotarsky","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"33","key":"key\n\t\t\t\t20170715051736_bib11","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M603670200","article-title":"GPR92 as a new G12\/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem."},{"issue":"3","key":"key\n\t\t\t\t20170715051736_bib12","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.bbrc.2007.09.063","article-title":"The orphan GPCR GPR87 was deorphanized and shown to be a lysophosphatidic acid receptor","volume":"363","author":"Tabata","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"key\n\t\t\t\t20170715051736_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.84","article-title":"G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth","volume":"40","author":"Pasternack","year":"2008","journal-title":"Nat Genet."},{"issue":"4","key":"key\n\t\t\t\t20170715051736_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2008.04.145","article-title":"Identification of the orphan GPCR, P2Y(10) receptor as the sphingosine-1-phosphate and lysophosphatidic acid receptor","volume":"371","author":"Murakami","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"key\n\t\t\t\t20170715051736_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1073\/pnas.0135855100","article-title":"Identification of an intracellular receptor for lysophosphatidic acid (LPA): LPA is a transcellular PPARgamma agonist","volume":"100","author":"McIntyre","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib16","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1084\/jem.20031619","article-title":"Lysophosphatidic acid induces neointima formation through PPARgamma activation","volume":"199","author":"Zhang","year":"2004","journal-title":"J Exp Med"},{"issue":"2","key":"key\n\t\t\t\t20170715051736_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/gyno.2001.6124","article-title":"Lysophospholipids increase interleukin-8 expression in ovarian cancer cells","volume":"81","author":"Schwartz","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170715051736_bib18","doi-asserted-by":"crossref","first-page":"9653","DOI":"10.1074\/jbc.M306662200","article-title":"Mechanisms for lysophosphatidic acid-induced cytokine production in ovarian cancer cells","volume":"279","author":"Fang","year":"2004","journal-title":"J Biol Chem."},{"issue":"10","key":"key\n\t\t\t\t20170715051736_bib19","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/jnci\/93.10.762","article-title":"Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells","volume":"93","author":"Hu","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"key\n\t\t\t\t20170715051736_bib20","first-page":"3704","article-title":"Lysophosphatidic acid induces urokinase secretion by ovarian cancer cells","volume":"5","author":"Pustilnik","year":"1999","journal-title":"Clin Cancer Res."},{"issue":"5","key":"key\n\t\t\t\t20170715051736_bib21","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1158\/0008-5472.CAN-05-2947","article-title":"Lysophosphatidic acid is a major regulator of growth-regulated oncogene alpha in ovarian cancer","volume":"66","author":"Lee","year":"2006","journal-title":"Cancer Res."},{"issue":"22","key":"key\n\t\t\t\t20170715051736_bib22","doi-asserted-by":"crossref","first-page":"6598","DOI":"10.1158\/1078-0432.CCR-06-1721","article-title":"Of spiders and crabs: the emergence of lysophospholipids and their metabolic pathways as targets for therapy in cancer","volume":"12","author":"Murph","year":"2006","journal-title":"Clin Cancer Res."},{"issue":"3","key":"key\n\t\t\t\t20170715051736_bib23","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1172\/JCI114784","article-title":"Ascitic fluid from human ovarian cancer patients contains growth factors necessary for intraperitoneal growth of human ovarian adenocarcinoma cells","volume":"86","author":"Mills","year":"1990","journal-title":"J Clin Invest"},{"issue":"pt 3","key":"key\n\t\t\t\t20170715051736_bib24","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1042\/bj3090933","article-title":"Lysophospholipids activate ovarian and breast cancer cells","volume":"309","author":"Xu","year":"1995","journal-title":"Biochem J"},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/jcb.20113","article-title":"Lysophosphatidic acid production and action: validated targets in cancer?","volume":"92","author":"Umezu-Goto","year":"2004","journal-title":"J Cell Biochem"},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib26","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1158\/0008-5472.CAN-05-1292","article-title":"Lysophosphatidic acid is constitutively produced by human peritoneal mesothelial cells and enhances adhesion, migration, and invasion of ovarian cancer cells","volume":"66","author":"Ren","year":"2006","journal-title":"Cancer Res."},{"issue":"2","key":"key\n\t\t\t\t20170715051736_bib27","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1083\/jcb.200204026","article-title":"Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production","volume":"158","author":"Umezu-Goto","year":"2002","journal-title":"J Cell Biol."},{"issue":"10 pt 1","key":"key\n\t\t\t\t20170715051736_bib28","first-page":"3534","article-title":"Role of decreased levels of lipid phosphate phosphatase-1 in accumulation of lysophosphatidic acid in ovarian cancer","volume":"9","author":"Tanyi","year":"2003","journal-title":"Clin Cancer Res."},{"issue":"5","key":"key\n\t\t\t\t20170715051736_bib29","first-page":"1073","article-title":"The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer","volume":"63","author":"Tanyi","year":"2003","journal-title":"Cancer Res."},{"key":"key\n\t\t\t\t20170715051736_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1749-6632.2000.tb06550.x","article-title":"Lysophospholipid growth factors in the initiation, progression, metastases, and management of ovarian cancer","volume":"905","author":"Fang","year":"2000","journal-title":"Ann NY Acad Sci."},{"issue":"1\u20133","key":"key\n\t\t\t\t20170715051736_bib31","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1388-1981(02)00179-8","article-title":"Lysophosphatidic acid is a bioactive mediator in ovarian cancer","volume":"1582","author":"Fang","year":"2002","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"key\n\t\t\t\t20170715051736_bib32","first-page":"4308","article-title":"Overexpression of edg-2\/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner","volume":"5","author":"Furui","year":"1999","journal-title":"Clin Cancer Res."},{"issue":"2","key":"key\n\t\t\t\t20170715051736_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/1097-0215(200102)9999:9999<::AID-IJC1166>3.0.CO;2-D","article-title":"Lysophosphatidic acid, a novel lipid growth factor for human thyroid cells: over-expression of the high-affinity receptor edg4 in differentiated thyroid cancer","volume":"92","author":"Schulte","year":"2001","journal-title":"Int J Cancer"},{"issue":"10","key":"key\n\t\t\t\t20170715051736_bib34","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/labinvest.3700146","article-title":"Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer","volume":"84","author":"Shida","year":"2004","journal-title":"Lab Invest J Tech Method Pathol"},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib35","doi-asserted-by":"crossref","first-page":"R640","DOI":"10.1186\/bcr935","article-title":"Over-expression of lysophosphatidic acid receptor-2 in human invasive ductal carcinoma","volume":"6","author":"Kitayama","year":"2004","journal-title":"Br Cancer Res."},{"issue":"16","key":"key\n\t\t\t\t20170715051736_bib36","doi-asserted-by":"crossref","first-page":"7983","DOI":"10.1158\/0008-5472.CAN-05-4381","article-title":"Hypoxia enhances lysophosphatidic acid responsiveness in ovarian cancer cells and lysophosphatidic acid induces ovarian tumor metastasis in vivo","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"key\n\t\t\t\t20170715051736_bib37","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1074\/jbc.M210151200","article-title":"Rac activation by lysophosphatidic acid LPA1 receptors through the guanine nucleotide exchange factor Tiam1","volume":"278","author":"Van Leeuwen","year":"2003","journal-title":"J Biol Chem."},{"issue":"17","key":"key\n\t\t\t\t20170715051736_bib38","doi-asserted-by":"crossref","first-page":"17634","DOI":"10.1074\/jbc.M313927200","article-title":"Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1","volume":"279","author":"Hama","year":"2004","journal-title":"J Biol Chem."},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/jnci\/90.6.447","article-title":"Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice","volume":"90","author":"Yoneda","year":"1998","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"key\n\t\t\t\t20170715051736_bib40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1158\/1541-7786.MCR-06-0338","article-title":"Lysophosphatidic acid decreases the nuclear localization and cellular abundance of the p53 tumor suppressor in A549 lung carcinoma cells","volume":"5","author":"Murph","year":"2007","journal-title":"Mol Cancer Res."},{"issue":"4","key":"key\n\t\t\t\t20170715051736_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1021\/bc010002o","article-title":"Avidin-dendrimer-(1B4M-Gd)(254): a tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI","volume":"12","author":"Kobayashi","year":"2001","journal-title":"Bioconjug Chem."},{"issue":"1","key":"key\n\t\t\t\t20170715051736_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1525-1438.2000.00003.x","article-title":"Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel","volume":"10","author":"Penson","year":"2000","journal-title":"Int J Gynecol Cancer"},{"issue":"11","key":"key\n\t\t\t\t20170715051736_bib43","first-page":"3445","article-title":"Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype","volume":"5","author":"Duan","year":"1999","journal-title":"Clin Cancer Res."},{"issue":"2C","key":"key\n\t\t\t\t20170715051736_bib44","first-page":"1149","article-title":"Vascular endothelial growth factor (VEGF) concentration in sera and tumor effusions from patients with ovarian carcinoma","volume":"24","author":"Harlozinska","year":"2004","journal-title":"Anticancer Res."},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib45","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1525-1438.2003.13601.x","article-title":"Targeted therapy for epithelial ovarian cancer: current status and future prospects","volume":"13","author":"See","year":"2003","journal-title":"Int J Gynecol Cancer"},{"issue":"20","key":"key\n\t\t\t\t20170715051736_bib46","first-page":"5370","article-title":"Distinctive expression and functions of the type 4 endothelial differentiation gene-encoded G protein-coupled receptor for lysophosphatidic acid in ovarian cancer","volume":"59","author":"Goetzl","year":"1999","journal-title":"Cancer Res."},{"issue":"11","key":"key\n\t\t\t\t20170715051736_bib47","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1096\/fj.02-1145fje","article-title":"A novel laminin-induced LPA autocrine loop in the migration of ovarian cancer cells","volume":"17","author":"Sengupta","year":"2003","journal-title":"FASEB J"},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib48","first-page":"2482","article-title":"Constitutive and lysophosphatidic acid (LPA)-induced LPA production: role of phospholipase D and phospholipase A2","volume":"6","author":"Eder","year":"2000","journal-title":"Clin Cancer Res."},{"issue":"10","key":"key\n\t\t\t\t20170715051736_bib49","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1194\/jlr.M300188-JLR200","article-title":"Role of phospholipase D in agonist-stimulated lysophosphatidic acid synthesis by ovarian cancer cells","volume":"44","author":"Luquain","year":"2003","journal-title":"J Lipid Res."},{"issue":"6","key":"key\n\t\t\t\t20170715051736_bib50","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1158\/0008.5472.CAN-04-2781","article-title":"Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells","volume":"65","author":"Symowicz","year":"2005","journal-title":"Cancer Res."},{"issue":"32","key":"key\n\t\t\t\t20170715051736_bib51","doi-asserted-by":"crossref","first-page":"22786","DOI":"10.1074\/jbc.M512486200","article-title":"Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis","volume":"281","author":"Baker","year":"2006","journal-title":"J Biol Chem."},{"issue":"1","key":"key\n\t\t\t\t20170715051736_bib52","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bbalip.2006.10.001","article-title":"Inhibition of transcellular tumor cell migration and metastasis by novel carba-derivatives of cyclic phosphatidic acid","volume":"1771","author":"Uchiyama","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"5","key":"key\n\t\t\t\t20170715051736_bib53","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.semcdb.2004.05.001","article-title":"Mechanisms of lysophosphatidic acid production","volume":"15","author":"Aoki","year":"2004","journal-title":"Semin Cell Dev Biol."},{"issue":"5","key":"key\n\t\t\t\t20170715051736_bib54","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/jcb.20126","article-title":"Lipid phosphate phosphatases and related proteins: signaling functions in development, cell division, and cancer","volume":"92","author":"Brindley","year":"2004","journal-title":"J Cell Biochem"},{"issue":"9","key":"key\n\t\t\t\t20170715051736_bib55","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1210\/jcem.85.9.6793","article-title":"A gonadotropin-releasing hormone-responsive phosphatase hydrolyses lysophosphatidic acid within the plasma membrane of ovarian cancer cells","volume":"85","author":"Imai","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20170715051736_bib56","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0378-1119(01)00410-3","article-title":"The mouse lp(A3)\/Edg7 lysophosphatidic acid receptor gene: genomic structure, chromosomal localization, and expression pattern","volume":"267","author":"Contos","year":"2001","journal-title":"Gene"},{"issue":"1","key":"key\n\t\t\t\t20170715051736_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/sj.onc.1206986","article-title":"Induction of protein growth factor systems in the ovaries of transgenic mice overexpressing human type 2 lysophosphatidic acid G protein-coupled receptor (LPA2)","volume":"23","author":"Huang","year":"2004","journal-title":"Oncogene"},{"issue":"1\u20132","key":"key\n\t\t\t\t20170715051736_bib58","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0014-5793(00)01827-5","article-title":"Lysophosphatidic acid (LPA) receptors of the EDG family are differentially activated by LPA species. Structure-activity relationship of cloned LPA receptors","volume":"478","author":"Bandoh","year":"2000","journal-title":"FEBS Lett."},{"issue":"12","key":"key\n\t\t\t\t20170715051736_bib59","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1172\/JCI200422123","article-title":"Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer","volume":"114","author":"Boucharaba","year":"2004","journal-title":"J Clin Invest"},{"issue":"25","key":"key\n\t\t\t\t20170715051736_bib60","doi-asserted-by":"crossref","first-page":"9643","DOI":"10.1073\/pnas.0600979103","article-title":"The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases","volume":"103","author":"Boucharaba","year":"2006","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/100\/22\/1630\/18614291\/djn378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T09:53:24Z","timestamp":1557914004000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djn378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":60,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2008,11,19]]},"published-print":{"date-parts":[[2008,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djn378","relation":{},"ISSN":["0027-8874","1460-2105"],"issn-type":[{"value":"0027-8874","type":"print"},{"value":"1460-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}